Pharmaceutical Stocks To Keep An Eye On – March 4th

Eli Lilly and Company, Johnson & Johnson, and Honeywell International are the three Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks represent shares in companies engaged in discovering, developing, manufacturing, and marketing medications and health-related products. They tend to be sensitive to factors such as regulatory decisions, clinical trial outcomes, and market dynamics, which can result in significant volatility and potential for high rewards alongside elevated risks. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

NYSE:LLY traded down $12.82 on Tuesday, reaching $916.90. The stock had a trading volume of 1,941,314 shares, compared to its average volume of 3,711,270. The stock has a fifty day moving average price of $817.56 and a 200-day moving average price of $848.11. The company has a quick ratio of 0.97, a current ratio of 1.15 and a debt-to-equity ratio of 2.00. Eli Lilly and Company has a 1-year low of $711.40 and a 1-year high of $972.53. The company has a market capitalization of $869.38 billion, a P/E ratio of 78.30, a price-to-earnings-growth ratio of 1.40 and a beta of 0.42.

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

Shares of NYSE JNJ traded down $0.72 during mid-day trading on Tuesday, hitting $166.56. The company’s stock had a trading volume of 6,475,334 shares, compared to its average volume of 6,990,527. The company’s fifty day simple moving average is $151.33 and its 200-day simple moving average is $156.08. Johnson & Johnson has a one year low of $140.68 and a one year high of $169.86. The stock has a market cap of $401.02 billion, a price-to-earnings ratio of 25.04, a price-to-earnings-growth ratio of 2.56 and a beta of 0.52. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.11 and a quick ratio of 0.86.

Honeywell International (HON)

Honeywell International Inc. engages in the aerospace technologies, building automation, energy and sustainable solutions, and industrial automation businesses in the United States, Europe, and internationally. The company’s Aerospace segment offers auxiliary power units, propulsion engines, integrated avionics, environmental control and electric power systems, engine controls, flight safety, communications, navigation hardware, data and software applications, radar and surveillance systems, aircraft lighting, advanced systems and instruments, satellite and space components, and aircraft wheels and brakes; spare parts; repair, overhaul, and maintenance services; and thermal systems, as well as wireless connectivity services.

HON stock traded down $2.16 during trading hours on Tuesday, reaching $209.86. 3,580,319 shares of the stock were exchanged, compared to its average volume of 4,174,685. The company has a market cap of $136.39 billion, a price-to-earnings ratio of 24.03, a PEG ratio of 2.51 and a beta of 1.05. Honeywell International has a 12 month low of $189.75 and a 12 month high of $242.77. The firm’s 50-day moving average is $218.27 and its 200-day moving average is $216.07. The company has a debt-to-equity ratio of 1.33, a current ratio of 1.31 and a quick ratio of 1.01.